Ericka Simpson

6.3k total citations · 1 hit paper
26 papers, 1.6k citations indexed

About

Ericka Simpson is a scholar working on Neurology, Genetics and Organic Chemistry. According to data from OpenAlex, Ericka Simpson has authored 26 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Neurology, 10 papers in Genetics and 3 papers in Organic Chemistry. Recurrent topics in Ericka Simpson's work include Amyotrophic Lateral Sclerosis Research (17 papers), Neurogenetic and Muscular Disorders Research (9 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). Ericka Simpson is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (17 papers), Neurogenetic and Muscular Disorders Research (9 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). Ericka Simpson collaborates with scholars based in United States, Australia and Canada. Ericka Simpson's co-authors include Stanley H. Appel, Alan Pestronk, Timothy M. Miller, Peggy Allred, Merit Cudkowicz, David Schoenfeld, Eric A. Macklin, William David, Matthew J. Crisp and Edward G. D. Tuddenham and has published in prestigious journals such as PLoS ONE, Brain and Neurology.

In The Last Decade

Ericka Simpson

26 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study

2013 492 citations Timothy M. Miller, Alan Pestronk et al. The Lancet Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ericka Simpson United States	15	757	552	518	313	255	26	1.6k
Ericka P. Simpson United States	16	1.3k 1.7×	420 0.8×	627 1.2×	534 1.7×	196 0.8×	20	1.7k
Jennifer Gass United States	17	1.2k 1.5×	777 1.4×	360 0.7×	310 1.0×	153 0.6×	36	2.1k
Yasuko Toyoshima Japan	28	1.6k 2.1×	977 1.8×	252 0.5×	538 1.7×	679 2.7×	85	2.7k
Michael L. Garcia United States	20	1.1k 1.5×	850 1.5×	749 1.4×	423 1.4×	500 2.0×	37	2.2k
Gerald Goodall United Kingdom	15	801 1.1×	457 0.8×	358 0.7×	321 1.0×	108 0.4×	19	1.3k
Po‐Min Chiang Taiwan	13	549 0.7×	516 0.9×	380 0.7×	122 0.4×	152 0.6×	24	1.1k
Shixiang Wen United States	12	814 1.1×	304 0.6×	309 0.6×	667 2.1×	90 0.4×	19	1.4k
Virginia Rodriguez‐Menendez Italy	21	146 0.2×	507 0.9×	177 0.3×	81 0.3×	202 0.8×	47	1.4k
Pieter J.L.M. Snijders Netherlands	14	319 0.4×	260 0.5×	334 0.6×	126 0.4×	223 0.9×	22	1.1k

Countries citing papers authored by Ericka Simpson

Since Specialization

Citations

This map shows the geographic impact of Ericka Simpson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ericka Simpson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ericka Simpson more than expected).

Fields of papers citing papers by Ericka Simpson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ericka Simpson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ericka Simpson. The network helps show where Ericka Simpson may publish in the future.

Co-authorship network of co-authors of Ericka Simpson

This figure shows the co-authorship network connecting the top 25 collaborators of Ericka Simpson. A scholar is included among the top collaborators of Ericka Simpson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ericka Simpson. Ericka Simpson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shroff, Sheetal, et al.. (2019). Immune-Mediated Neuropathies. Current Treatment Options in Neurology. 21(6). 28–28. 12 indexed citations

Berry, James D., Sabrina Paganoni, Nazem Atassi, et al.. (2015). A Phase IIa Double-Blind, Placebo-Controlled Study to Evaluate the Safety of Oral Fingolimod In Patients with Amyotrophic Lateral Sclerosis (ALS) (P7.067). Neurology. 84(14_supplement). 1 indexed citations

Wang, Yunxia, Dan H. Moore, Jonathan Katz, et al.. (2015). A multi-center screening trial of rasagiline in patients with amyotrophic lateral sclerosis: Possible mitochondrial biomarker target engagement. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 16(5-6). 345–352. 23 indexed citations

Harms, Matthew, Janet Cady, Erica Koval, et al.. (2014). The TREM2 Variant p.R47H is a Risk Factor for Sporadic Amyotrophic Lateral Sclerosis (I5-2.002). Neurology. 82(10_supplement). 1 indexed citations

McElhiney, Martin, Judith G. Rabkin, Raymond R. Goetz, et al.. (2014). Seeking a measure of clinically meaningful change in ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 15(5-6). 398–405. 13 indexed citations

Cady, Janet, Erica Koval, Bruno A. Benítez, et al.. (2014). TREM2Variant p.R47H as a Risk Factor for Sporadic Amyotrophic Lateral Sclerosis. JAMA Neurology. 71(4). 449–449. 214 indexed citations

Harms, Matthew, Janet Cady, Erica Koval, et al.. (2014). The TREM2 Variant p.R47H is a Risk Factor for Sporadic Amyotrophic Lateral Sclerosis (I5-2.002). 82. 1 indexed citations

Miller, Timothy M., Alan Pestronk, William David, et al.. (2013). An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study. The Lancet Neurology. 12(5). 435–442. 492 indexed citations breakdown →

Berry, James D., Jeremy M. Shefner, Robin Conwit, et al.. (2013). Design and Initial Results of a Multi-Phase Randomized Trial of Ceftriaxone in Amyotrophic Lateral Sclerosis. PLoS ONE. 8(4). e61177–e61177. 73 indexed citations

10.

Ilieva, Hristelina, Neil M. Vora, & Ericka Simpson. (2013). Initial Maximal Inspiratory Pressure (MIP) and Forced Vital Capacity (FVC) Correlate with Disability Levels at Times of ALS Diagnosis (P07.081). Neurology. 80(7_supplement). 1 indexed citations

11.

Nicholson, Garth A., Guy M. Lenk, Stephen Reddel, et al.. (2011). Distinctive genetic and clinical features of CMT4J: a severe neuropathy caused by mutations in the PI(3,5)P2 phosphatase FIG4. Brain. 134(7). 1959–1971. 96 indexed citations

12.

Jawaid, Ali, Santosh B. Murthy, A WILSON, et al.. (2010). A decrease in body mass index is associated with faster progression of motor symptoms and shorter survival in ALS. Amyotrophic Lateral Sclerosis. 11(6). 542–548. 111 indexed citations

13.

Jawaid, Ali, Santosh B. Murthy, Diane Mosnik, et al.. (2010). Association between dysarthria and cognitive impairment in ALS: A prospective study. Amyotrophic Lateral Sclerosis. 11(1-2). 46–51. 20 indexed citations

14.

Jawaid, Ali, Adriana M. Strutt, Santosh B. Murthy, et al.. (2010). ALS disease onset may occur later in patients with pre‐morbid diabetes mellitus. European Journal of Neurology. 17(5). 733–739. 70 indexed citations

15.

Jawaid, Ali, Emily J. McDowell, Salah U. Qureshi, et al.. (2010). Does apolipoprotein E genotype modify the clinical expression of ALS?. European Journal of Neurology. 18(4). 618–624. 16 indexed citations

16.

Jawaid, Ali, Santosh B. Murthy, Diane Mosnik, et al.. (2009). Association between dysarthria and cognitive impairment in ALS: A prospective study. Amyotrophic Lateral Sclerosis. 1–6. 2 indexed citations

17.

Cudkowicz, Merit, J. Katz, Dan H. Moore, et al.. (2009). Toward more efficient clinical trials for amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis. 11(3). 259–265. 57 indexed citations

18.

Milone, Margherita, Nicola Brunetti‐Pierri, Neeraj Kumar, et al.. (2008). Sensory ataxic neuropathy with ophthalmoparesis caused by POLG mutations. Neuromuscular Disorders. 18(8). 626–632. 52 indexed citations

19.

Yen, Albert, Ericka Simpson, Lanny J. Haverkamp, & Stanley H. Appel. (2004). Design using historical controls. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders. 5(sup1). 61–63. 2 indexed citations

20.

Croaker, Geoffrey David Hain, et al.. (1998). Congenital central hypoventilation syndrome and Hirschsprung's disease. Archives of Disease in Childhood. 78(4). 316–322. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact